Telix Pharmaceuticals TLX
NASDAQ TLX
$9.51 +0.25 (+2.70%)
At close: Oct 29, 2026 · 4:00 PM EDT

Telix Pharmaceuticals (TLX) Non-Current Deferred Tax Liability (2024 - 2026)

Updated

Telix Pharmaceuticals' Non-Current Deferred Tax Liability came in at $43.3 million for the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Non-Current Deferred Tax Liability (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, Telix Pharmaceuticals' Non-Current Deferred Tax Liability was $44.71 million, up 671.3% from the prior year.

  • Going back by year, Non-Current Deferred Tax Liability was $5.8 million in the year ended Dec 31, 2024.
  • The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Non-Current Deferred Tax Liability since the quarter ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.17 Bn 1,237.79 Bn 20.46 Bn
2 Johnson & Johnson 660.04 Bn 579.90 Bn 17.30 Bn
3 AbbVie 521.06 Bn 494.17 Bn 12.70 Bn
4 Merck 370.60 Bn 370.60 Bn -
5 Novartis Ag 311.97 Bn 285.20 Bn -
6 Astrazeneca 288.69 Bn 262.37 Bn 12.86 Bn
7 Amgen 252.29 Bn 207.69 Bn 7.24 Bn
8 Gilead Sciences 213.47 Bn 213.47 Bn -
9 Pfizer 173.68 Bn 120.32 Bn 10.94 Bn
10 Telix Pharmaceuticals 3.07 Bn 2.03 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 43.30 Mn
Dec 31, 2025 44.71 Mn
Dec 31, 2024 5.83 Mn
API Access

Telix Pharmaceuticals Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=TLX&period=max&api_key=YOUR_API_KEY